Valuation Aprogen Biologics Inc.

Stocks

End-of-day quote Korea S.E. 2026-10-30			5-day change	1st Jan Change
1,335.00 ^KRW	-3.26%		-3.75%	-82.85%

09-22	Aprogen Biologics Inc. announced that it has received KRW 20.0000011 billion in funding from Aprogen Medicines Inc.	CI
09-02	Aprogen Biologics Inc. announced that it expects to receive KRW 20.0000011 billion in funding from Aprogen Medicines Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	524,120	360,706	200,481	190,684	130,793	102,540
Change	-	-31.18%	-44.42%	-4.89%	-31.41%	-21.6%
Enterprise Value (EV) ¹	322,016	238,252	236,145	361,628	246,492	279,703
Change	-	-26.01%	-0.88%	53.14%	-31.84%	13.47%
P/E	37.6x	45.3x	26.5x	-1.55x	-0.79x	-0.6x
PBR	1.04x	0.71x	0.7x	0.52x	0.35x	0.49x
PEG	-	-1.1x	-5.3x	0x	0x	-0.18x
Capitalization / Revenue	9.83x	6.39x	3.08x	2.18x	1.94x	1.4x
EV / Revenue	6.04x	4.22x	3.62x	4.14x	3.66x	3.82x
EV / EBITDA	378x	-125x	-24x	-7.34x	-6.24x	-2.7x
EV / EBIT	-298x	-59.9x	-19.3x	-5.12x	-4.21x	-2.28x
EV / FCF	-10.8x	-2.45x	2.37x	25.9x	-10.3x	-3.38x
FCF Yield	-9.23%	-40.8%	42.1%	3.87%	-9.75%	-29.6%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	5,250	3,000	2,850	-28,122	-12,525	-12,932
Distribution rate	-	-	-	-	-	-
Net sales ¹	53,320	56,482	65,190	87,364	67,378	73,226
EBITDA ¹	851.3	-1,903	-9,837	-49,292	-39,486	-103,705
EBIT ¹	-1,081	-3,975	-12,241	-70,690	-58,577	-122,889
Net income ¹	11,253	8,103	7,837	-118,270	-104,979	-170,331
Net Debt ¹	-202,104	-122,454	35,664	170,944	115,698	177,163
Reference price ²	197,250.00	135,750.00	75,450.00	43,500.00	9,930.00	7,785.00
Nbr of stocks (in thousands)	2,657	2,657	2,657	4,384	13,172	13,172
Announcement Date	3/12/21	3/14/22	3/17/23	3/13/24	3/14/25	3/20/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
APROGEN BIOLOGICS INC.	-	-	-	-	16.2M
ELI LILLY AND COMPANY	41.42x	14.04x	31.11x	0.48%	1,263B
JOHNSON & JOHNSON	39.99x	6.71x	18.89x	1.95%	658B
ABBVIE INC.	36.71x	8.6x	17.71x	2.33%	521B
ROCHE HOLDING AG	21.74x	5.27x	13.12x	2.48%	391B
MERCK & CO., INC.	106.24x	6.06x	25.8x	2.28%	369B
NOVARTIS AG	23.19x	5.95x	14.36x	2.69%	307B
ASTRAZENECA PLC	24.47x	4.89x	13.59x	1.77%	290B
AMGEN INC.	29.55x	7.53x	13.48x	2.16%	252B
GILEAD SCIENCES, INC.	-41.18x	7.46x	46.76x	1.93%	212B
Average	31.35x	7.39x	21.65x	2.01%	426.19B
Weighted average by Cap.	37.16x	8.83x	22.81x	1.69%